CAS 182507-22-8
:Raloxifeno-4-glucurónido
- (4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy-D4]benzoyl]benzo[b]thien-2-yl]phenyl-D-glucopyranosiduronic acid)
- 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy-d4]benzoyl]benzo[b]thien-2-yl]phenyl-b-D-glucopyranosiduronic Acid
- 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl β-<span class="text-smallcaps">D</span>-glucopyranosiduronic acid
- 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl-D-glucopyranosiduronicacid
- 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl-b-D-glucopyranosiduronic Acid
- Raloxifene-D4-4'-Glucuronide
- β-<span class="text-smallcaps">D</span>-Glucopyranosiduronic acid, 4-[6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl
- β-D-Glucopyranosiduronic acid, 4-[6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl
- Raloxifene 4′-glucuronide
- Raloxifene-d4-4'-glucuronide lithiuM salt
- Raloxifene-4'-glucuronide lithiuM salt
- Raloxifene-4'-D-glucuronide lithium salt
- Ver más sinónimos
4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl β-D-glucopyranosiduronic acid
CAS:Fórmula:C34H35NO10SForma y color:SolidPeso molecular:649.7074Raloxifene-4'-Glucuronide
CAS:Fórmula:C34H35NO10SForma y color:Pale Yellow SolidPeso molecular:649.71Raloxifene 4'-glucuronide
CAS:Raloxifene 4'-glucuronide is a primary metabolite of Raloxifene.Fórmula:C34H35NO10SPureza:98%Forma y color:SolidPeso molecular:649.71Raloxifene-4'-Glucuronide Lithium Salt
CAS:Fórmula:C34H34NO10S·LiForma y color:Yellow SolidPeso molecular:648.70 6.94Raloxifene-d4 4'-Glucuronide
CAS:Producto controladoFórmula:C34D4H31NO10SForma y color:NeatPeso molecular:653.732Raloxifene 4’-Glucuronide
CAS:Producto controladoApplications A metabolite of Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist.
References Dodge, J., et al.: Bioorg. Med. Chem. Lett., 7, 993 (1997), Jeong, E., et al.: Drug Metab. Dispos., 33, 785 (2005), Trontelj, J., et al.: Pharmacol. Res., 52, 334 (2005), Oswald, S., et al.: Clin. Pharmacol. Ther., 79 206 (2006),Fórmula:C34H35NO10SForma y color:NeatPeso molecular:649.71Raloxifene 4'-D-glucuronide
CAS:Raloxifene 4'-D-glucuronide is a drug that is a prodrug of raloxifene, and it can be used to treat osteoporosis. The compound is metabolized by glucuronidation in the liver, and it has been found to have bioequivalence with the parent drug. Raloxifene 4'-D-glucuronide is marketed under the trade name Evista.Fórmula:C34H35NO10SPureza:Min. 95%Forma y color:PowderPeso molecular:649.71 g/molRaloxifene 4’-Beta-D-Glucuronide Lithium Salt
CAS:Producto controladoStability Hygroscopic
Applications Raloxifene 4’-Glucuronide Lithium Salt is a metabolite of Raloxifene (R099995), a nonsteroidal estrogen receptor mixed agonist/antagonist.
References Dodge, J., et al.: Bioorg. Med. Chem. Lett., 7, 993 (1997); Jeong, E., et al.: Drug Metab. Dispos., 33, 785 (2005); Trontelj, J., et al.: Pharmacol. Res., 52, 334 (2005); Oswald, S., et al.: Clin. Pharmacol. Ther., 79 206 (2006)Fórmula:C34H34LiNO10SForma y color:NeatPeso molecular:655.64Raloxifene-d4 4’-β-D-Glucuronide Lithium Salt
CAS:Producto controladoFórmula:C34D4H31NO10S·LiForma y color:NeatPeso molecular:660.673Raloxifene-4'-D-glucuronide lithium salt
CAS:Raloxifene-4'-D-glucuronide lithium salt is a metabolite of raloxifene, an estrogen receptor modulator. It has been used in the treatment of osteoporosis and breast cancer. Raloxifene-4'-D-glucuronide lithium salt inhibits protein synthesis by inhibiting the activity of ribosomes. Raloxifene-4'-D-glucuronide lithium salt binds to microsomal preparations, which are organelles found in liver cells that synthesize proteins. This binding slows down the rate at which proteins are synthesized, leading to its anti-cancer properties.Fórmula:C34H34NO10S·LiPureza:Min. 95%Peso molecular:655.64 g/mol







